怀孕,抗发作药物和无法解释的子宫内胎儿死亡
Frank J E Vajda1, Terence J O'Brien2, Janet E Graham3
1Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia; Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia.
Epilepsy & behavior : E&B
|March 5, 2024
概括
虽然产前抗发作药物 (ASM) 暴露可能会略微增加子宫内胎儿死亡 (IUFD) 风险,但非药物因素对患有的孕妇 (WWE) 更加重要.
科学领域:
- 产科和妇科 产科和妇科
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 会影响孕妇,需要谨慎管理抗发作药物 (ASM).
- 了解怀孕期间与ASM相关的风险,特别是子宫内胎儿死亡 (IUFD),对于改善母亲和胎儿的结果至关重要.
研究的目的:
- 评估抗发作药物 (ASM) 治疗方案与其他因素与性孕妇子宫内胎儿死亡 (IUFD) 之间的关联.
- 分析劳尔·瓦伦伯格澳大利亚抗药物怀孕登记册 (APR) 的数据,以确定IUFD的危险因素.
主要方法:
- 来自澳大利亚抗药物怀孕注册表 (APR) 的2,323例妇女怀孕的前性研究.
- 统计分析以确定与子宫内胎儿死亡 (IUFD) 相关的因素,包括母亲的年龄,入学时的怀孕阶段和药物使用.
主要成果:
- 胎内死亡 (IUFD) 在3.01%的怀孕中发生.
- 与IUFD相关的因素包括母亲的年龄较大,早期的怀孕登记,先前的怀孕流产,父母有胎儿形史,以及使用卡巴马兹,拉莫特里金或埃索克西米德.
- 与多个ASM一起观察到IUFD的风险增加,但在调整为混因素后,这种风险减弱了.
结论:
- 产前接触抗发作药物 (ASM) 可能与子宫内胎儿死亡 (IUFD) 的风险增加有关.
- 非药理学因素似乎在患有的孕妇 (WWE) 中对IUFD的贡献更为重要.
- 需要进一步的研究来阐明影响IUFD的因素的复杂相互作用.
更多相关视频
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
01:17Antiepileptic Drugs: Calcium Channel Blockers
393
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
393
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
01:08Antiepileptic Drugs: Sodium Channel Blockers
551
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
551
01:24Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296